Treatment strategy after noncurative endoscopic resection for early gastric cancers in patients aged ≥ 85 years: a multicenter retrospective study in a highly aged area of Japan.
Early gastric cancers
Noncurative endoscopic resection
Patients aged ≥ 85 years
eCura system
Journal
Journal of gastroenterology
ISSN: 1435-5922
Titre abrégé: J Gastroenterol
Pays: Japan
ID NLM: 9430794
Informations de publication
Date de publication:
04 2023
04 2023
Historique:
received:
07
09
2022
accepted:
24
12
2022
medline:
30
3
2023
pubmed:
13
1
2023
entrez:
12
1
2023
Statut:
ppublish
Résumé
The guidelines recommend additional gastrectomy after noncurative endoscopic resection for early gastric cancers (EGCs). However, no additional treatment might be acceptable in some patients aged ≥ 85 years. We aimed to identify this patient group using the data in a highly aged area. We enrolled patients aged ≥ 85 years after noncurative endoscopic resection for EGCs at 30 institutions of the Tohoku district in Japan between 2002 and 2017. Treatment selection and prognosis after noncurative endoscopic resection were investigated. Fourteen candidates were evaluated using the Cox model to identify risk factors for poor overall survival (OS) in patients with no additional treatment. Of 1065 patients aged ≥ 85 years, 143 underwent noncurative endoscopic resection. Despite the guidelines' recommendation, 88.8% of them underwent no additional treatment. The 5-year OS rates in those with additional gastrectomy and those with no additional treatment were 63.1 and 65.2%, respectively. Multivariate analysis showed independent risk factors for poor OS in patients with no additional treatment were the high-risk category in the eCura system (hazard ratio [HR], 2.91), Charlson comorbidity index (CCI) ≥ 3 (HR, 2.78), and male (HR, 2.04). In patients with no additional treatment, nongastric cancer-specific survival was low (69.0% in 5 years), whereas disease-specific survival rates were very high in the low- and intermediate-risk categories of the eCura system (100.0 and 97.1%, respectively, in 5 years). No additional treatment may be acceptable in the low- and intermediate-risk categories of the eCura system in patients aged ≥ 85 years with noncurative endoscopic resection for EGCs.
Sections du résumé
BACKGROUND
The guidelines recommend additional gastrectomy after noncurative endoscopic resection for early gastric cancers (EGCs). However, no additional treatment might be acceptable in some patients aged ≥ 85 years. We aimed to identify this patient group using the data in a highly aged area.
METHODS
We enrolled patients aged ≥ 85 years after noncurative endoscopic resection for EGCs at 30 institutions of the Tohoku district in Japan between 2002 and 2017. Treatment selection and prognosis after noncurative endoscopic resection were investigated. Fourteen candidates were evaluated using the Cox model to identify risk factors for poor overall survival (OS) in patients with no additional treatment.
RESULTS
Of 1065 patients aged ≥ 85 years, 143 underwent noncurative endoscopic resection. Despite the guidelines' recommendation, 88.8% of them underwent no additional treatment. The 5-year OS rates in those with additional gastrectomy and those with no additional treatment were 63.1 and 65.2%, respectively. Multivariate analysis showed independent risk factors for poor OS in patients with no additional treatment were the high-risk category in the eCura system (hazard ratio [HR], 2.91), Charlson comorbidity index (CCI) ≥ 3 (HR, 2.78), and male (HR, 2.04). In patients with no additional treatment, nongastric cancer-specific survival was low (69.0% in 5 years), whereas disease-specific survival rates were very high in the low- and intermediate-risk categories of the eCura system (100.0 and 97.1%, respectively, in 5 years).
CONCLUSIONS
No additional treatment may be acceptable in the low- and intermediate-risk categories of the eCura system in patients aged ≥ 85 years with noncurative endoscopic resection for EGCs.
Identifiants
pubmed: 36633664
doi: 10.1007/s00535-022-01948-7
pii: 10.1007/s00535-022-01948-7
doi:
Types de publication
Multicenter Study
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
346-357Informations de copyright
© 2023. Japanese Society of Gastroenterology.
Références
Pilleron S, Sarfati D, Janssen-Heijnen M, et al. Global cancer incidence in older adults, 2012 and 2035: a population-based study. Int J Cancer. 2019;144:49–58.
doi: 10.1002/ijc.31664
pubmed: 29978474
Bray F, Ferlay J, Laversanne M, et al. cancer incidence in five continents: inclusion criteria, highlights from volume X and the global status of cancer registration. Int J Cancer. 2015;137:2060–71.
doi: 10.1002/ijc.29670
pubmed: 26135522
Scotte F, Bossi P, Carola E, et al. Addressing the quality of life needs of older patients with cancer: a SIOG consensus paper and practical guide. Ann Oncol. 2018;29:1718–26.
doi: 10.1093/annonc/mdy228
pubmed: 30010772
Hatta W, Gotoda T, Koike T, et al. Management following endoscopic resection in elderly patients with early-stage upper gastrointestinal neoplasia. Dig Endosc. 2020;32:861–73.
doi: 10.1111/den.13592
pubmed: 31802529
Pimentel-Nunes P, Libanio D, Bastiaansen BAJ, et al. Endoscopic submucosal dissection for superficial gastrointestinal lesions: European Society of Gastrointestinal Endoscopy (ESGE) Guideline-Update 2022. Endoscopy. 2022;54:591–622.
doi: 10.1055/a-1811-7025
pubmed: 35523224
Japanese Gastric Cancer Association. Japanese gastric cancer treatment guidelines 2018 (5
doi: 10.1007/s10120-020-01042-y
Ono H, Yao K, Fujishiro M, et al. Guidelines for endoscopic submucosal dissection and endoscopic mucosal resection for early gastric cancer (second edition). Dig Endosc. 2021;33:4–20.
doi: 10.1111/den.13883
pubmed: 33107115
Hatta W, Gotoda T, Kanno T, et al. Prevalence and risk factors for lymph node metastasis after noncurative endoscopic resection for early gastric cancer: a systematic review and meta-analysis. J Gastroenterol. 2020;55:742–53.
doi: 10.1007/s00535-020-01685-9
pubmed: 32277297
Hatta W, Gotoda T, Oyama T, et al. Is radical surgery necessary in all patients who do not meet the curative criteria for endoscopic submucosal dissection in early gastric cancer? A multi-center retrospective study in Japan. J Gastroenterol. 2017;52:175–84.
doi: 10.1007/s00535-016-1210-4
pubmed: 27098174
Suzuki H, Takizawa K, Hirasawa T, et al. Short-term outcomes of multicenter prospective cohort study of gastric endoscopic resection: real-world evidence in Japan. Dig Endosc. 2019;31:30–9.
doi: 10.1111/den.13246
pubmed: 30058258
Esaki M, Hatta W, Shimosegawa T, et al. Age affects clinical management after noncurative endoscopic submucosal dissection for early gastric cancer. Dig Dis. 2019;37:423–33.
doi: 10.1159/000499538
pubmed: 31096243
Nunobe S, Oda I, Ishikawa T, et al. Surgical outcomes of elderly patients with Stage I gastric cancer from the nationwide registry of the Japanese Gastric Cancer Association. Gastric Cancer. 2020;23:328–38.
doi: 10.1007/s10120-019-01000-3
pubmed: 31451990
Yoshifuku Y, Oka S, Tanaka S, et al. Long-term prognosis after endoscopic submucosal dissection for early gastric cancer in super-elderly patients. Surg Endosc. 2016;30:4321–9.
doi: 10.1007/s00464-016-4751-y
pubmed: 26850026
Sekiguchi M, Oda I, Suzuki H, et al. Clinical outcomes and prognostic factors in gastric cancer patients aged ≥85 years undergoing endoscopic submucosal dissection. Gastrointest Endosc. 2017;85:963–72.
doi: 10.1016/j.gie.2016.10.013
pubmed: 27751873
Iwai N, Dohi O, Naito Y, et al. Impact of the Charlson comorbidity index and prognostic nutritional index on prognosis in patients with early gastric cancer after endoscopic submucosal dissection. Dig Endosc. 2018;30:616–23.
doi: 10.1111/den.13051
pubmed: 29532961
Ogata Y, Hatta W, Ohara Y, et al. Predictors of early and late mortality after the treatment for early gastric cancers. Dig Endosc. 2022;34:816–25.
doi: 10.1111/den.14172
pubmed: 34662456
Toya Y, Endo M, Nakamura S, et al. Long-term outcomes and prognostic factors with non-curative endoscopic submucosal dissection for gastric cancer in elderly patients aged ≥ 75 years. Gastric Cancer. 2019;22:838–44.
doi: 10.1007/s10120-018-00913-9
pubmed: 30560475
Waki K, Shichijo S, Uedo N, et al. Long-term outcomes after endoscopic resection for late-elderly patients with early gastric cancer. Gastrointest Endosc. 2022;95:873–83.
doi: 10.1016/j.gie.2021.12.028
pubmed: 34979116
Statistics Bureau, Ministry of Internal Affairs and Communications, Government of Japan (2021) Annual report of population estimates (in Japanese). [Accessed 19 Aug 2022.] Available from https://www.stat.go.jp/data/jinsui/pdf/202201.pdf
United Nations. World Population Prospects: the 2019 Revision. New York: United Nations, Department of economic and social affairs, population division (2019). [Accessed 19 Aug 2022.] Available from https://population.un.org/wpp/Publications/Files/WPP2019-Wallchart.pdf
Cabinet Office, Government of Japan (2020) Report of aging population in areas (in Japanese). [Accessed 19 Aug 2022.] Available from https://www8.cao.go.jp/kourei/whitepaper/w-2020/zenbun/pdf/1s1s_04.pdf
Population Division UN. World population ageing 1950–2050. New York: United Nations Digital Library; 2002.
Toya Y, Shimada T, Hamada K, et al. Prediction model of 3-year survival after endoscopic submucosal dissection for early gastric cancer in elderly patients aged ≥ 85 years: EGC-2 model. J Cancer Res Clin Oncol. 2022. https://doi.org/10.1007/s00432-022-04024-y .
doi: 10.1007/s00432-022-04024-y
pubmed: 35546359
Japanese Gastric Cancer Association. Japanese classification of gastric carcinoma 3rd English edition. Gastric Cancer. 2011;14:101–12.
doi: 10.1007/s10120-011-0041-5
Hatta W, Gotoda T, Oyama T, et al. A scoring system to stratify curability after endoscopic submucosal dissection for early gastric cancer: “eCura system.” Am J Gastroenterol. 2017;112:874–81.
doi: 10.1038/ajg.2017.95
pubmed: 28397873
Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40:373–83.
doi: 10.1016/0021-9681(87)90171-8
pubmed: 3558716
Dolan RD, Daly L, Sim WMJ, et al. Comparison of the prognostic value of ECOG-PS, mGPS and BMI/WL: implications for a clinically important framework in the assessment and treatment of advanced cancer. Clin Nutr. 2020;39:2889–95.
doi: 10.1016/j.clnu.2019.12.024
pubmed: 31926762
Grenader T, Waddell T, Peckitt C, et al. Prognostic value of neutrophil-to-lymphocyte ratio in advanced oesophago-gastric cancer: exploratory analysis of the REAL-2 trial. Ann Oncol. 2016;27:687–92.
doi: 10.1093/annonc/mdw012
pubmed: 26787231
Proctor MJ, Morrison DS, Talwar D, et al. A comparison of inflammation-based prognostic scores in patients with cancer. A Glasgow Inflammation Outcome Study. Eur J Cancer. 2011;47:2633–41.
doi: 10.1016/j.ejca.2011.03.028
pubmed: 21724383
Onodera T, Goseki N, Kosaki G. Prognostic nutritional index in gastrointestinal surgery of malnourished cancer patients. Nihon Geka Gakkai Zasshi. 1984;85:1001–5 (Japanese).
pubmed: 6438478
Hatta W, Gotoda T, Koike T, et al. A recent argument for the use of endoscopic submucosal dissection for rarly gastric cancers. Gut Liver. 2020;14:412–22.
doi: 10.5009/gnl19194
pubmed: 31554392
Peduzzi P, Concato J, Kemper E, et al. A simulation study of the number of events per variable in logistic regression analysis. J Clin Epidemiol. 1996;49:1373–9.
doi: 10.1016/S0895-4356(96)00236-3
pubmed: 8970487
Hatta W, Gotoda T, Koike T, et al. Is additional gastrectomy required for elderly patients after endoscopic submucosal dissection with endoscopic curability C-2 for early gastric cancer? Digestion. 2022;103:83–91.
doi: 10.1159/000519514
pubmed: 34638125